Metabolic glycan engineering is a technique that uses monosaccharide analogs to install unnatural sugars into the glycocalyx of mammalian cells and has recently been used to label and target cancer cells. In this technique, cells are incubated with monosaccharide analogs bearing unnatural chemical groups (e.g., azides, thiols, ketones, etc.), and these monosaccharides are processed by biosynthetic enzymes in a manner analogous to their natural precursors, resulting in cell surface glycans bearing unnatural chemical groups. At CD BioGlyco, our GlycoCLICK™-based Labeling Service has been consistently well-received by our clients. Our azide-based GlycoCLICK™-based Cell Surface Glycan Labeling Service enables glycan labeling by combining our GlycoCLICK™ technology with metabolic glycan engineering. The azide-modified glycan molecules or fluorescent probes are used to react directly with cell surface glycan structures to achieve selective labeling and detection of specific glycan structures. The azide-based cell surface glycan labeling services we provide include but are not limited to:
By introducing these glycans into the cell, we effectively introduce azides into the cell surface glycan structure. The introduced azide reacts with specific reagents to achieve selective labeling of cell surface glycans. After the reaction, the labeled cell surface glycan structure shows fluorescence or signal enhancement. This enables the labeled cells to be visualized and analyzed by imaging techniques such as fluorescence microscopy, thus helping your research on the distribution, composition, and dynamics of the glycans.
Technology: Cell culture, metabolic glycan engineering, and time-resolved fluorescence resonance energy transfer (TR-FRET)
Journal: Journal of the American Chemical Society
IF: 16.383
Published: 2017
Results: This article develops a general strategy for analyzing receptor-ligand interactions by using homogenous TR-FRET and metabolic glycan engineering techniques to enable any receptor of interest to be equipped with an FRET donor, independent of antibodies or genetic engineering. The researchers applied metabolic glycosyl engineering technology to introduce a metabolic glycosyl into cells and then used click chemistry to bind a probe with azadibenzocyclooctyne (ADIBO)-terbium chelate to the glycosyl in the cells. The GlycoFRET method was then used to measure the receptor-ligand interaction. This method is convenient as it does not require a washing step after the cells have been processed with the probe. This homogeneous analytical method can provide a simplified binding assay in a high-throughput screening environment and is an attractive alternative to radioassay methods.
Fig.1 Process of GlycoFRET assay in live cell. (Stockmann, et al., 2017)
CD BioGlyco is a company dedicated to the research and application of glycans. Our team of experts collaborates with clients to develop optimal experimental protocols based on experimental needs and target cell types to offer azide-based cell surface glycan labeling services. Please feel free to
if you have any inquiries regarding our services.Reference